▲ Peaking
Business
🔮 holds
Pharmaceutical Executive
Coverage by Pharmaceutical Executive as tracked by Newsylist.
9trends covered
0broke first
9articles tracked
◼ Archived
Business
🔮 holds ✗
Novartis secures new radioligand in $900M deal as competition strengthens
◼ Archived
Business
🔮 holds ✗
Novartis inks $3.2B subcutaneous delivery deal with Alteogen
◼ Archived
Business
🔮 fades ✓
There’s a big change for this year’s flu shot: When should you be vaccinated?
◼ Archived
Business
🔮 holds ✗
The peptide craze has hit Florida hard. What you need to know.
◼ Archived
Business
🔮 holds ✗
FDA approves Otsuka’s ADHD drug Simtriyo, teeing up its ‘next major CNS launch’
The FDA has granted approval to Otsuka for Simtriyo, marking the introduction of the first triple reuptake inhibitor for the treatment of ADHD.
◼ Archived
Business
🔮 holds ✗
Johns Hopkins surgeon highlights AI breakthrough that could spot pancreatic cancer before doctors
Healthcare leaders are balancing the integration of advanced AI diagnostic tools with the necessity of maintaining human-centric patient care.
◼ Archived
Business
🔮 holds ✓
Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
Sanofi's Sarclisa becomes the first cancer drug approved by the FDA for delivery via an on-body injector for multiple myeloma.
◼ Archived
Business
🔮 fades ✓
EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials
A US House committee has launched an investigation into drug trials conducted in China by major pharmaceutical companies, including Merck and AbbVie.